Atopic dermatitis is a chronic inflammatory skin disorder affecting approximately 10% of US adults and children.1,2 The condition is the result of multiple factors including a hyperstimulated cutaneous immune system, a genetically determined compromised skin barrier, and exposure to triggering environmental stimuli. Flares manifest as extreme pruritus of red, rough, flaky and often fissured regions of the skin that become chronically thickened, rough, and discolored. Atopic dermatitis can have a profound effect on the quality of life of patients and their families through effects on sleep, behavior, mood, and absences from school and work.3 The topical therapies discussed in this guideline4 are considered the first line of management.
Stein SL, Cifu AS. Management of Atopic Dermatitis. JAMA. 2016;315(14):1510–1511. doi:10.1001/jama.2016.1459
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: